Circulation Research

Deletion of BACH1 Attenuates Atherosclerosis by Reducing Endothelial Inflammation.  130:1038-1055. 2022

Research Goes Red: Early Experience with a Participant-Centric Registry.  130:343-351. 2022

Fak activation promotes smc dedifferentiation via increased dna methylation in contractile genes.  129:E215-E233. 2021

Resident macrophages in the heart: Cardioprotective under pressure.  129:1102-1104. 2021

Novel Mechanisms of Exosome-Mediated Phagocytosis of Dead Cells in Injured Heart.  129:1006-1020. 2021

Activation of Autophagic Flux Blunts Cardiac Ischemia/Reperfusion Injury.  129:435-450. 2021

Cardiac Energy Metabolism in Heart Failure.  128:1487-1513. 2021

Epigenetic Age Acceleration Reflects Long-Term Cardiovascular Health.  770-781. 2021

Diabetes Impairs Cellular Cholesterol Efflux from ABCA1 to Small HDL Particles.  127:1198-1210. 2020

In Situ Expansion, Differentiation, and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid.  127:207-224. 2020

Chronobiological influence over cardiovascular function the good, the bad, and the ugly.  258-279. 2020

The heart of the (gray) matter is not black and white.  765-766. 2020

Race, Natriuretic Peptides, and High-Carbohydrate Challenge: A Clinical Trial.  125:957-968. 2019

Response by Pfeffer et al to Letter Regarding Article, "heart Failure with Preserved Ejection Fraction in Perspective".  125:E26. 2019

Heart Failure with Preserved Ejection Fraction in Perspective.  124:1598-1617. 2019

Treatment of Resistant and Refractory Hypertension.  124:1061-1070. 2019

Expression of Concern: Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery (Circulation Research (2014) 129 (157-172) DOI: 10.1161/CIRCULATIONAHA.113.006591).  124:e4-e5. 2019

Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure.  124:161-169. 2019

Lower blood pressure thresholds raise the bar in pregnancy.  125:195-197. 2019

Nuclear focal adhesion kinase controls vascular smooth muscle cell proliferation and neointimal hyperplasia through GATA4-mediated cyclin D1 transcription.  125:152-166. 2019

Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates.  122:958-969. 2018

E2F1 suppresses oxidative metabolism and endothelial differentiation of bone marrow progenitor cells.  122:701-711. 2018

CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.  122:88-96. 2018

Mitochondrial Reactive Oxygen Species in Lipotoxic Hearts Induce Post-Translational Modifications of AKAP121, DRP1, and OPA1 That Promote Mitochondrial Fission.  122:58-73. 2018

Can we engineer a human cardiac patch for therapy?.  123:244-265. 2018

Effective metabolic approaches for the energy starved failing heart: Bioenergetic resiliency via redundancy or something else?.  123:329-331. 2018

Multifunctional role of chymase in acute and chronic tissue injury and remodeling.  122:319-336. 2018

Relationship between the efficacy of cardiac cell therapy and the inhibition of differentiation of human iPSC-Derived nonmyocyte cardiac cells into Myofibroblast-like cells.  123:1313-1325. 2018

Sprinting toward the optimal blood pressure target for hypertensive patients.  123:531-534. 2018

Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR-125b.  123:564-578. 2018

PDK4 Inhibits Cardiac Pyruvate Oxidation in Late Pregnancy.  121:1370-1378. 2017

Impact of VA Research on Health Care for All: Contributions over Nine Decades and Counting.  121:16-18. 2017

Meeting Report for the 2017 National Institutes of Health National Heart, Lung, and Blood Institute Progenitor Cell Biology Consortium: Cardiovascular Bioengineering Workshop and Symposium.  120:1709-1712. 2017

Immunomodulation is the key to cardiac repair.  120:1530-1532. 2017

Myocardial Tissue Engineering with Cells Derived from Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold.  120:1318-1325. 2017

Reprogrammed Human Endothelial Cells: A Novel Cell Source for Regenerative Vascular Medicine..  120:756-758. 2017

Meta-Analysis of Genome-Wide Association Studies for Abdominal Aortic Aneurysm Identifies Four New Disease-Specific Risk Loci.  120:341-353. 2017

From Microscale Devices to 3D Printing: Advances in Fabrication of 3D Cardiovascular Tissues.  120:150-165. 2017

A special report on the NHLBI initiative to study cellular and molecular mechanisms of arterial stiffness and its association with hypertension.  121:1216-1218. 2017

Lactate promotes synthetic phenotype in vascular smooth muscle cells.  121:1251-1262. 2017

Crossing into the Next Frontier of Cardiac Extracellular Matrix Research.  119:1040-1045. 2016

Meeting Report for NIH 2016 Progenitor Cell Biology Consortium Cardiovascular Tissue Engineering 2016.  119:981-983. 2016

Response by Zhou et al to Letter Regarding Article, Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy.  119:e29-e30. 2016

The biological basis for cardiac repair after myocardial infarction.  119:91-112. 2016

Assessing Cardiac Metabolism.  118:1659-1701. 2016

Loss of adult cardiac myocyte GSK-3 leads to mitotic catastrophe resulting in fatal dilated cardiomyopathy.  118:1208-1222. 2016

A large-scale investigation of hypoxia-preconditioned allogeneic mesenchymal stem cells for myocardial repair in nonhuman primates: Paracrine activity without remuscularization.  118:970-983. 2016

Cardio-oncology: An update on cardiotoxicity of cancer-related treatment.  118:1008-1020. 2016

CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels..  118:230-240. 2016

Enhanced Reprogramming of Human Fibroblasts into Cardiomyocytes Using Minimal Transcription Factors.  119:A35-A35. 2016

The Nervous Heart: Role of Sympathetic Reinnervation in Cardiac Regeneration..  117:980-981. 2015

Genetic Deficiency of Glutathione S-Transferase P Increases Myocardial Sensitivity to Ischemia-Reperfusion Injury.  117:437-449. 2015

Bach1 represses Wnt/β-catenin signaling and angiogenesis.  117:364-375. 2015

Embryonic Stem Cell-Derived Exosomes Promote Endogenous Repair Mechanisms and Enhance Cardiac Function Following Myocardial Infarction.  117:52-64. 2015

New Approaches in the Treatment of Hypertension.  116:1074-1095. 2015

The GSK-3 family as therapeutic target for myocardial diseases.  116:138-149. 2015

PGC-1α induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle.  115:504-517. 2014

OxLDL Triggers Retrograde Translocation of Arginase2 in Aortic Endothelial Cells via ROCK and Mitochondrial Processing Peptidase.  115:450-459. 2014

Sorafenib cardiotoxicity increases mortality after myocardial infarction.  114:1700-1712. 2014

Activation of AKT by O-linked N-Acetylglucosamine induces vascular calcification in diabetes mellitus.  114:1094-1102. 2014

It takes two to tango: Monocyte and macrophage duality in the infarcted heart.  114:1558-1560. 2014

Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure critical importance of the cardiosplenic axis.  114:266-282. 2014

Gli3 regulation of myogenesis is necessary for ischemia-induced angiogenesis.  113:1148-1158. 2013

Patching the heart: Cardiac repair from within and outside.  113:922-932. 2013

The never-ending story of angiotensin peptides: Beyond angiotensin i and II.  112:1086-1087. 2013

Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype.  111:1176-1189. 2012

Metabolic remodeling in the hypertrophic heart: Fuel for thought.  111:666-668. 2012

Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.  111:543-552. 2012

Bioenergetic and functional consequences of cellular therapy: Activation of endogenous Cardiovascular progenitor cells.  111:455-468. 2012

Enhanced angiogenic and cardiomyocyte differentiation capacity of epigenetically reprogrammed mouse and human endothelial progenitor cells augments their efficacy for ischemic myocardial repair.  111:180-190. 2012

Orai1 determines calcium selectivity of an endogenous trpc heterotetramer channel.  110:1435-1444. 2012

Role of RyR2 phosphorylation at S2814 during heart failure progression.  110:1474-1483. 2012

Elucidating nature's solutions to heart, lung, and blood diseases and sleep disorders.  110:915-921. 2012

Inhalation of nitric oxide prevents ischemic brain damage in experimental stroke by selective dilatation of collateral arterioles.  110:727-738. 2012

Response to the letter by Edwards et al.  110. 2012

Animal models of heart failure a scientific statement from the American Heart Association.  111:131-150. 2012

Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels.  109:1259-1268. 2011

Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium.  109:1280-1289. 2011

Exosomes from human CD34⁺ stem cells mediate their proangiogenic paracrine activity.  109:724-728. 2011

PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.  109:783-793. 2011

Translational success stories: Angiotensin receptor 1 antagonists in heart failure.  109:437-452. 2011

Lack of primary cilia primes shear-induced endothelial-to-mesenchymal transition.  108:1093-1101. 2011

ATP production rate via creatine kinase or ATP synthase in Vivo: A novel superfast magnetization saturation transfer method.  108:653-663. 2011

Sustained hemodynamic stress disrupts normal circadian rhythms in calcineurin-dependent signaling and protein phosphorylation in the heart.  108:437-445. 2011

Genetic variation in NCAM1 contributes to left ventricular wall thickness in hypertensive families.  108:279-283. 2011

Late-breaking basic science abstracts from the American Heart Association's Scientific Sessions 2010.  107. 2010

CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity.  107:1083-1093. 2010

PGC-1 coactivators in cardiac development and disease.  107:825-838. 2010

Increased endothelial exocytosis and generation of endothelin-1 contributes to constriction of aged arteries.  107:242-251. 2010

Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARα.  107:233-241. 2010

Decreased S-nitrosylation of tissue transglutaminase contributes to age-related increases in vascular stiffness.  107:117-125. 2010

Glycogen synthase kinase-3β regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.  106:1635-1645. 2010

Peroxisome proliferator-activated receptor δ is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart.  106:911-919. 2010

The cardiomyocyte circadian clock: Emerging roles in health and disease.  106:647-658. 2010

Short communication: Ischemia/reperfusion tolerance is time-of-day- dependent: Mediation by the cardiomyocyte circadian clock.  106:546-550. 2010

Career moves: Induced pluripotent cells from human aortic smooth muscle cells can efficiently redifferentiate into parental phenotype.  106:7-9. 2010

Nitro-fatty acid inhibition of neointima formation after endoluminal vessel injury.  105:965-972. 2009

Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.  105:897-905. 2009

Direct Relationship Between Protein O-GlcNAcylation and the Cardiomyocyte Circadian Clock.  105:E50-E50. 2009

Increased Cardiomyocyte 0-linked-beta-N-acetylglucosamine (0-GlcNAc) Levels Induced by Glucose Deprivation Mediated by Decreased 0-GlcNAcase Expression and Reduced Hexosamine Biosynthesis Flux.  105:E34-E35. 2009

O-linked-beta-N-acetylglucosamine (O-GlcNAc) Mediated Ischemic Cardioprotection Associated with Increased O-GlcNAcylation of Cytoskeletal Z-Line Proteins.  105:E13-E13. 2009

Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression.  104:1209-1216. 2009

Inducible Expression of Active Protein Phosphatase-1 Inhibitor-1 Enhances Basal Cardiac Function and Protects Against Ischemia/Reperfusion Injury.  104:1012-1020. 2009

IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR.  104. 2009

Arrhythmogenic effects of β2-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load.  102:1389-1397. 2008

Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair.  102. 2008

Intramural foci during long duration fibrillation in the pig ventricle.  102:1256-1264. 2008

Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog.  102:1127-1136. 2008

Endothelial arginase II: A novel target for the treatment of atherosclerosis.  102:923-932. 2008

Interleukin-1β causes acute lung injury via αvβ5 and αvβ6 integrin-dependent mechanisms.  102:804-812. 2008

Negative-feedback loop attenuates hydrostatic lung edema via a cGMP-dependent regulation of transient receptor potential vanilloid 4.  102:966-974. 2008

Ca2+/calmodulin-dependent protein kinase IIδ and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure.  102:695-702. 2008

c-kit is required for cardiomyocyte terminal differentiation.  102:677-685. 2008

Atrial natriuretic peptide inhibits transforming growth factor β-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts.  102:185-192. 2008

Role of mitochondrial dysfunction in insulin resistance.  102:401-414. 2008

Intra-sarcoplasmic reticulum free [Ca2+] and buffering in arrhythmogenic failing rabbit heart.  101:802-810. 2007

STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: Analysis of molecular signaling and therapeutic efficacy of cardiomyocyte precommitted mES transplantation in a mouse model of myocardial infarction.  101:910-918. 2007

Inducible NO synthase-dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction.  101:692-702. 2007

Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis.  100:1703-1711. 2007

Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration.  100:654-661. 2007

Myocyte nitroso-redox imbalance in sepsis: NO simple answer.  100:1-4. 2007

The role of O-GlcNAcylation in aging-related loss of estrogenic vasoprotection.  99:1282-1282. 2006

APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase/Akt pathway via the phosphoinositol phosphatase SHIP2.  99:829-836. 2006

Free radicals, mitochondria, and oxidized lipids: The emerging role in signal transduction in vascular cells.  99:924-932. 2006

Oxidized low-density lipoprotein-dependent endothelial arginase II activation contributes to impaired nitric oxide signaling.  99:951-960. 2006

Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function.  98:1098-1105. 2006

Coupled and uncoupled NOS: Separate but equal? Uncoupled NOS in endothelial cells is a critical pathway for intracellular signaling.  98:717-719. 2006

Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity.  98:119-124. 2006

Ca²⁺/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca²⁺ leak in heart failure.  97:1314-1322. 2005

Activation of the endothelial store-operated ISOC Ca ²⁺ channel requires interaction of protein 4.1 with TRPC4.  97:1164-1172. 2005

An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-I.  97:1085-1086. 2005

Expression and phosphorylation of the Na-pump regulatory subunit phospholemman in heart failure.  97:558-565. 2005

Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.  97:524-532. 2005

Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide.  97:236-243. 2005

Glucosamine-induced cardioprotection mediated by the hexosamine biosynthesis pathway and increased levels of O-linked N-acetylglucosamine on nucleocytoplasmic proteins.  97:E28-E28. 2005

Adenoviral gene transfer of mutant phospholamban rescues contractile dysfunction in failing rabbit myocytes with relatively preserved SERCA function.  96:815-817. 2005

Essential role of a Ca²⁺-selective, store-operated current (ISOC) in endothelial cell permeability determinants of the vascular leak site.  96:856-863. 2005

Low-voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes.  96:864-872. 2005

Increased PI3-kinase in presympathetic brain areas of the spontaneously hypertensive rat.  96:277-279. 2005

Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A.  96:54-63. 2005

Cytokine-induced modulation of cardiac function.  95:1140-1153. 2004

Apurinic/apyrmidinic endonuclease 1 regulates endothelial NO production and vascular tone.  95:902-910. 2004

Antiinflammatory properties of HDL.  95:764-772. 2004

Effects of electrical shocks on Cai²⁺ and V m in myocyte cultures.  94:1589-1597. 2004

Nitric oxide protects against pathological ventricular remodeling: Reconsideration of the role of NO in the failing heart.  94:1155-1157. 2004

Upregulation of Alveolar Epithelial Active Na⁺ Transport Is Dependent on β2-Adrenergic Receptor Signaling.  94:1091-1100. 2004

Estimated Global Transmural Distribution of Activation Rate and Conduction Block during Porcine and Canine Ventricular Fibrillation.  94:836-842. 2004

Genome-Wide Scan Identifies Novel QTLs for Cholesterol and LDL Levels in F2[Dahl RxS] Intercross Rats.  94:446-452. 2004

Nonlinear Changes of Transmembrane Potential, during Electrical Shocks: Role of Membrane Electroporation.  94:208-214. 2004

How do red blood cells dilate blood vessels?--Reply..  95. 2004

Elevated sarcoplasmic reticulum Ca²⁺ leak in intact ventricular myocytes from rabbits in heart failure.  93:592-594. 2003

CaV3.1 (α1G) T-type Ca²⁺ channels mediate vaso-occlusion of sickled erythrocytes in lung microcirculation.  93:346-353. 2003

Nitric oxide regulation of myocardial contractility and calcium cycling: Independent impact of neuronal and endothelial nitric oxide synthases.  92:1322-1329. 2003

Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.  92:741-748. 2003

Sustained reentry in the left ventricle of fibrillating pig hearts.  92:539-545. 2003

Vectorial sodium transport across the mammalian alveolar epithelium: It occurs but through which cells?.  92:348-349. 2003

Regional differences in ventricular fibrillation in the open-chest porcine left ventricle.  91:733-740. 2002

Effects of S-nitrosation and cross-linking of hemoglobin on hypoxic pulmonary vasoconstriction in isolated rat lungs.  91:626-632. 2002

Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor.  91:165-172. 2002

Optical mapping of arrhythmias induced by strong electrical shocks in myocyte cultures.  90:664-670. 2002

Intrinsic diurnal variations in cardiac metabolism and contractile function.  89:1199-1208. 2001

Recent fibrillation studies: Attempts to wrest order from disorder.  89:1089-1091. 2001

Nitric oxide synthase (NOS2) mutation in Dahl/Rapp rats decreases enzyme stability.  89:317-322. 2001

Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual β-adrenergic responsiveness.  88:1159-1167. 2001

Clock genes in the heart: Characterization and attenuation with hypertrophy.  88:1142-1150. 2001

Increased NA⁺-CA²⁺ exchanger in the failing heart.  87:641-643. 2000

Nonlinear changes of transmembrane potential during defibrillation shocks: Role of Ca²⁺ current.  87:453-459. 2000

Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells.  86:960-966. 2000

Fibrillating myocardium: Rabbit warren or beehive?.  86:369-370. 2000

Upregulation of Na⁺/Ca²⁺ exchanger expression and-function in an arrhythmogenic rabbit model of heart failure.  85:1009-1019. 1999

Shock-induced figure-of-eight reentry in the isolated rabbit heart.  85:742-752. 1999

The angiotensin II-dependent association of Jak2 and c-Src requires the N-terminus of Jak2 and the SH2 domain of c-Src.  84:1332-1338. 1999

Chemiluminescent detection of oxidants in vascular tissue: Lucigenin but not coelenterazine enhances superoxide formation.  84:1203-1211. 1999

Incidence, evolution, and spatial distribution of functional reentry during ventricular fibrillation in pigs.  84:945-954. 1999

Spatial changes in the transmembrane potential during extracellular electric stimulation.  83:1003-1014. 1998

ATP-sensitive K⁺ channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise.  82:346-359. 1998

Activation of cardiac tissue by extracellular electrical shocks: Formation of 'secondary sources' at intercellular clefts in monolayers of cultured myocytes.  82:375-385. 1998

Cyclic GMP-dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells.  82:139-146. 1998

Anisotropic Activation Spread in Heart Cell Monolayers Assessed by High-Resolution Optical Mapping: Role of Tissue Discontinuities.  79:115-127. 1996

Functional and structural assessment of intercellular communication: Increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes.  79:174-183. 1996

Spatial changes in transmembrane potential during extracellular electrical shocks in cultured monolayers of neonatal rat ventricular myocytes.  79:676-690. 1996

23Na and 31P nuclear magnetic resonance studies of ischemia-induced ventricular fibrillation. Alterations of intracellular Na+ and cellular energy..  77:394-406. 1995

Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite.  77:335-341. 1995

Optical transmembrane potential measurements during defibrillation- strength shocks in perfused rabbit hearts.  77:593-602. 1995

Regional capture of fibrillating ventricular myocardium: Evidence of an excitable gap.  77:849-855. 1995

Altered pulmonary microvascular reactivity to norepinephrine in canine pacing-induced heart failure.  75:347-356. 1994

Anisotropic conduction in monolayers of neonatal rat heart cells cultured on collagen substrate.  75:591-595. 1994

Computer simulations of three-dimensional propagation in ventricular myocardium: Effects of intramural fiber rotation and inhomogeneous conductivity on epicardial activation.  72:744-756. 1993

Coronary pressure-flow relation in left ventricular hypertrophy: Importance of changes in back pressure versus changes in minimum resistance.  72:579-587. 1993

Effects of monophasic and biphasic shocks on action potentials during ventricular fibrillation in dogs.  73:325-334. 1993

Epicardial mapping of ventricular defibrillation with monophasic and biphasic shocks in dogs.  72:145-160. 1993

Microscopic conduction in cultured strands of neonatal rat heart cells measured with voltage-sensitive dyes.  73:914-925. 1993

Optical measurements of transmembrane potential changes during electric field stimulation of ventricular cells.  72:255-270. 1993

Effect of field stimulation on cellular repolarization in rabbit myocardium: Implications for reentry induction.  70:707-715. 1992

Existence of both fast and slow channel activity during the early stages of ventricular fibrillation.  70:773-786. 1992

Kinetics of restitution of left ventricular relaxation.  70:29-38. 1992

Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells.  69:1427-1449. 1991

Prolongation of repolarization time by electric field stimulation with monophasic and biphasic shocks in open-chest dogs.  68:1761-1767. 1991

Comparison of activation during ventricular fibrillation and following unsuccessful defibrillation shocks in open-chest dogs.  66:1544-1560. 1990

Conduction disturbances caused by high current density electric fields.  66:1190-1203. 1990

Correlation between transmural high energy phosphate levels and myocardial blood flow in the presence of graded coronary stenosis.  67:660-673. 1990

Differences in myosin isoform expression in the subepicardial and subendocardial myocardium during cardiac hypertrophy in the rat.  66:1127-1132. 1990

Differences in the electrophysiological response to canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium.  67:615-627. 1990

Increased ischemic injury but decreased hypoxic injury in hypertrophied rat hearts.  67:948-959. 1990

Mechanisms underlying the development of ventricular fibrillation during early myocardial ischemia.  66:672-695. 1990

Morphological development of the rat heart growing in oculo in the absence of hemodynamic work load.  66:84-102. 1990

Effects of ryanodine on contractile performance of intact length-clamped papillary muscle.  65:1270-1282. 1989

Vagally induced block and delayed conduction as a mechanism for circus movement tachycardia in frog atria.  64:213-226. 1989

Vascular remodeling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats.  64:1127-1136. 1989

Extracellular field required for excitation in three-dimensional anisotropic canine myocardium.  63:147-164. 1988

Maximal twitch tension in intact length-clamped ferret papillary muscles evoked by modified postextrasystolic potentiation.  62:65-74. 1988

Mechanism of ventricular vulnerability to single premature stimuli in open-chest dogs.  62:1191-1209. 1988

Transient outward current prominent in canine ventricular epicardium but not endocardium.  62:116-126. 1988

Transmural activations and stimulus potentials in three-dimensional anisotropic canine myocardium.  63:135-146. 1988

Reentrant and nonreentrant mechanisms contribute to arrhythmogenesis during early myocardial ischemia: Results using three-dimensional mapping.  61:352-371. 1987

Induction of delayed afterdepolarizations and triggered activity in canine Purkinje fibers by lysophosphoglycerides.  59:416-426. 1986

Sympathetic innervation alters growth and intrinsic heart rate of fetal rat atria maturing in oculo.  59:534-544. 1986

Differences in the determinants of overdrive suppression between sinus rhythm and slow atrioventricular junctional rhythm.  57:182-191. 1985

Histamine H1 receptor antagonists inhibit autoregulation of renal blood flow in the dog.  54:527-535. 1984

Effect of acute hypoxia on the pulmonary conversion of angiotensin I to angiotensin II in dogs.  46:221-226. 1980

Correlative electrophysiological and anatomical studies concerning the site of origin of escape rhythm during complete atrioventricular block in the dog.  45:108-119. 1979

Electrophysiological effects of magnesium on cells in the canine sinus node and false tendon.  44:182-188. 1979

Canine atrial and ventricular muscle mechanics studies as a function of age.  42:703-713. 1978

Equivalent generator properties of acute ischemic lesions in the isolated rabbit heart.  42:676-685. 1978

Hemodynamic components of a cardiogenic hypertensive chemoreflex in dogs.  42:135-142. 1978

Autoregulatory responses of superficial nephrons and their association with sodium excretion during arterial pressure alterations in the dog.  41:487-496. 1977

Detection and localization of multiple epicardial electrical generators by a two dipole ranging technique.  41:551-557. 1977

Development of left ventricular hypertrophy in young spontaneously hypertensive rats after peripheral sympathectomy.  40:428-434. 1977

Path and significance of heart vector migration during QRS and ST-T complexes of ectopic beats in isolated perfused rabbit hearts.  41:558-564. 1977

Relation of renal hemodynamics to metabolism of angiotensin II by the canine kidney.  41:283-287. 1977

Relative dipolar behavior of the equivalent T wave generator. Quantitative comparison with ventricular excitation in the rabbit heart.  40:263-268. 1977

Spontaneous action potentials of cells in the canine sinus node.  39:76-82. 1976

Comparison of contractile performance of canine atrial and ventricular muscles.  37:762-771. 1975

Localization of heart vectors produced by epicardial burns and ectopic stimuli. Validation of a dipole ranging method.  36:105-112. 1975

Structural requirements for substrates and inhibitors of angiotensin I converting enzyme in vivo and in vitro.  34:19-26. 1974

Mechanism of renal handling of angiotensin II in the dog.  33:500-507. 1973

Pitfalls in digital computation of the impulse response of vascular beds from indicator dilution curves.  32:516-523. 1973

Substrate requirements for angiotensin I conversion in vivo and in vitro..  32:415-423. 1973

Mechanism of pulmonary conversion of angiotensin I to angiotensin II in the dog..  29:682-690. 1971

In-vivo and in-vitro conversion of angiotensin I to angiotensin II in dog blood..  26:591-599. 1970